Michel De Waard is a group leader at the Institut du Thorax and a senior research director at Inserm, the French medical institute. He has co-authored or directed close to 300 publications in peer review journals. His main focus is on drug discovery from natural sources and on peptide engineering for technology and health. He is also the founder of a private company, Smartox Biotechnology, which specializes in the chemical synthesis of complex peptides.